Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine and Valsartan Tablets, USP 10/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., NDC 0378-1724-93.

D-0323-2019

December 04, 2018

Class II

Product summary

Firm
Mylan Laboratories Limited, (Nashik FDF)
Event
Event 81707
Status
Ongoing
Classification
Class II
Quantity
84,066 HDPE bottles
Official record key
drug-enforcement:D-0323-2019

Official wording

Reason: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Code information: Lot Numbers: 3066064, 3069645, 3069646, 3073142, 3073143, 3073144, 3077617

Distribution pattern: Product was distributed throughout the United States to several major distributors, including Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity, N-nitrosodiethylamine (NDEA